Brighton Jones LLC’s Juno Therapeutics, Inc. JUNO Stock Holding History

Brighton Jones LLC’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,444	Closed	-$340K	–	312
2017 Q4	$340K	Hold	7,444	–	–	0.04%	191
2017 Q3	$334K	Sell	7,444 -1,240	-14%	-$42.3K	0.04%	196
2017 Q2	$260K	Buy	+8,684	New	+$214K	0.04%	211
2016 Q3	–	Sell	-6,379	Closed	-$245K	–	244
2016 Q2	$245K	Buy	6,379 +1,059	+20%	+$44K	0.04%	171
2016 Q1	$203K	Buy	+5,320	New	+$185K	0.04%	198
2015 Q3	–	Sell	-4,130	Closed	-$220K	–	211
2015 Q2	$220K	Buy	+4,130	New	+$219K	0.05%	171

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Brighton Jones LLC's JUNO Position: Q1 2018 in Review

Brighton Jones LLC sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,444 shares — an estimated $340K sold.

Brighton Jones LLC first reported a position in JUNO in Q2 2015 and held it in 6 quarters. The position peaked at $340K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Brighton Jones LLC reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Brighton Jones LLC sold 7,444 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $340K.
Brighton Jones LLC first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
Brighton Jones LLC's Juno Therapeutics, Inc. position peaked at $340K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Brighton Jones LLC's 13F filing for Q1 2018, filed 3 May 2018.